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Abstract
Background: Hospital readmission for acute exacerbation of COPD (AECOPD) occurs in up to 30% of patients,
leading to excess morbidity and poor survival. Physiological risk factors predict readmission, but the impact of
modifiable psychosocial risk factors remains uncertain. We aimed to evaluate whether psychosocial risk factors
independently predict readmission for AECOPD in patients referred to early discharge services (EDS).
Methods: This prospective cohort study included 79 patients with AECOPD cared for by nurse led EDS in the UK,
and followed up for 12 months. Data on lung function, medical comorbidities, previous hospital admissions,
medications, and sociodemographics were collected at baseline; St George’s Respiratory Questionnaire (SGRQ),
Hospital Anxiety and Depression Scale (HADS), and social support were measured at baseline, 3 and 12-months.
Exploratory multivariate models were fitted to identify psychosocial factors associated with readmission adjusted for
known confounders.
Results: 26 patients were readmitted within 90 days and 60 patients were readmitted at least once during follow-
up. Depression at baseline predicted readmission adjusted for sociodemographics and forced expiratory volume in
1 second (odds ratio 1.30, 95% CI 1.06 to 1.60, p = 0.013). Perceived social support was not significantly associated
with risk of readmission. Home ownership was associated with the total number of readmissions (B = 0.46, 95% CI
-0.86 to -0.06, p = 0.024). Compared with those not readmitted, readmitted patients had worse SGRQ and HADS
scores at 12 months.
Conclusion: Depressive symptoms and socioeconomic status, but not perceived social support, predict risk of
readmission and readmission frequency for AECOPD in patients cared for by nurse-led EDS. Future work on
reducing demand for unscheduled hospital admissions could include the design and evaluation of interventions
aimed at optimising the psychosocial care of AECOPD patients managed at home.
Background
Readmission following hospital admission for acute
exacerbation of chronic obstructive pulmonary disease
(AECOPD) is common, occurring at least once in 60%
of patients within 1-year of discharge [1]. Furthermore,
rapid readmission within 3-months of discharge affect
30% of patients with AECOPD [2], and underscores the
fact that approximately one third of exacerbations are
recurrent events occurring within 8 weeks of an initial
exacerbation [3].
In Europe, early discharge services (EDS) are increas-
ingly the candidate care model to cost-effectively and
safely manage patients with AECOPD at home [4,5].
These services, which can care for 30% of patients
admitted for AECOPD, include admission prevention in
accident and emergency, rapid discharge (< 48 hours),
assisted discharge (≥ 2 days after admission), and nurse
led support in patients’ homes [6].
However, evidence that EDS reduce readmission rates
for AECOPD is equivocal. In a before and after study of
early discharge care followed by rapid-access out-patient
support, patients admitted for AECOPD had
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participation in the programme [7]. Similarly, in a Span-
ish study of patients with severe COPD, the provision of
an assisted discharge and exacerbation prevention pro-
gramme reduced readmission rates from 35% to 17%
[8]. By contrast, two UK trials showed that readmission
rates were not significantly different in patients rando-
mised to either EDS or standard in-patient care [9].
The reasons for readmission are complex. Previous
prospective studies have shown that independent risk
factors associated with COPD readmission include: poor
lung function [1,10,11], low p02 [1], previous hospital
admission [1,10], poor health related quality of life
(HRQOL) [10-12], cor pulmonale and inspiratory mus-
cle weakness [13]; hypercapnia at discharge [10]; low
levels of physical activity [1], and taking anticholinergic
drugs [1].
Whilst clinical and physiological parameters of COPD
are important determinants of readmission, modifiable
risk factors related to psychosocial status might also be
key drivers of unscheduled hospital care among COPD
patients [14]. Anxiety and depression are highly preva-
lent in stable COPD patients [15], and in patients dis-
charged after admission for AECOPD [16], but severity
of psychological distress is not associated with severity
of lung disease [17]. However, whilst severity of psycho-
logical distress is not associated with severity of lung
disease, associations between anxiety and depression
and poor HRQOL are greater in COPD patients with
severe-to-very severe disease and with two or more
medical comorbidities [18].
Despite growing understanding about the impact of
psychological distress on COPD, it remains uncertain
whether psychological factors increase risk of readmis-
sion. Dahlén and Janson [19] demonstrated that anxiety
and depression are associated with relapse (i.e. treat-
ment failure of a first exacerbation) within 1-month
after emergency treatment for COPD. However, where
studies have followed up COPD patients for 12 months,
results are contradictory. In patients with low health sta-
tus, anxiety but not depression may be an important risk
factor for hospital readmission in patients previously
admitted for AECOPD [11]. Ng et al similarly found
that depression was not independently associated with
risk of readmission in patients admitted for AECOPD
[20]. By contrast, Xu et al showed in a cohort of stable
COPD patients, that depression was significantly asso-
ciated with increased risk of exacerbation and hospital
admission [21].
There is also uncertainty about whether socioeco-
nomic factors and social support are risk factors for
readmission in COPD. Living with a partner is protec-
tive for men with severe COPD [22], but low social sup-
port as measured by marital status is associated with a
higher risk of readmission after adjustment for age and
sex [23]. Socioeconomic inequalities in education and
income are associated with a three-fold increase in risk
of hospital admission [24], but the availability of social
resources and material benefits do not appear to be
linked with readmission [1].
This study aimed to identify psychosocial risk factors
for readmission in a cohort of patients referred to EDS
after AECOPD, and followed up for one year. We
hypothesised that among this high risk and vulnerable
group, psychosocial factors would be associated with
risk of readmission regardless of disease severity and
other known covariates.
Methods
This was a cohort study of COPD patients admitted for
acute exacerbation to one of three acute hospitals in
Greater Manchester, UK, and then referred to a nurse
led EDS. Patients were recruited by specialist respiratory
nurses between 1
st May 2007 and 31
st August 2008.
Baseline assessments were taken within 1 week after
hospital discharge and at follow-up at 90 days and 365
days.
Eligibility criteria for referral to EDS included a vali-
dated diagnosis of COPD (ICD-10 codes J40-J44, J47),
and/or clinical history, with a post-bronchodilator forced
expiratory volume in 1 second (FEV1)<8 0 %o fp r e -
dicted, FEV/FVC ratio < 70%. Specialist respiratory
nurses were responsible for confirming the diagnosis of
COPD at the time of referral to EDS. Additional eligibil-
ity criteria for referral to EDS were: mini mental state >
7; systolic BP > 100 mmHg; white cell count (×10
9/l) 4-
20; potassium between 3.5 and 5 mmol/l; arterial blood
pH > 7.35; Po2 > 8 Kpa; PCo2 < 6.7 Kpa; registered with
a Manchester general practitioner and adequate social
support. Exclusion criteria were: suspected underlying
malignancy; pneumothorax; uncontrolled atrial fibrilla-
tion; acute ECG changes; required full time nursing;
needed intravenous therapy; cardiac chest pain; insulin
dependant diabetes; pneumonia/consolidation; chest X-
ray changes; pulmonary embolism; history of falls.
Only patients referred to EDS were eligible for entry
into the cohort study. Additional exclusion criteria for
the cohort study were patients with severe and enduring
mental health problems (psychosis and/or bipolar disor-
der) and not English language speaking.
Specialist respiratory nurses identified patients referred
to the EDS weekly and invited them to take part in the
cohort study at the point of discharge when they were
stable. Candidate participants were telephoned within
one week of discharge from hospital to arrange a home
v i s i t ,a n dt h e ns i g n e dc o n s e n ta n db a s e l i n ed a t aw e r e
obtained. All baseline and follow-up data were collected
by the principal investigator at patients’ homes. The
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pants’ baseline psychosocial status. Before home visits
the principal investigator telephoned the hospital nurse
teams to check that patients enrolled in the cohort
study were stable and well enough to complete outcome
assessments.
Outcomes
The primary outcome was readmission to hospital for
AECOPD within 365 days of index admission. We did
not distinguish between initial, isolated or recurrent
exacerbations, but all exacerbations were discrete events
separated by ≥7 days during which no additional symp-
toms were recorded [3]. Secondary outcomes were time
to first event (readmission or death), frequency and num-
ber of readmissions, and change in psychosocial status
over 365 days. Candidate predictor variables were anxiety
and depression symptoms, emotional and social support,
HRQOL, and socio-economic deprivation. It was
hypothesised that when controlling for known covariates,
psychosocial and socioeconomic factors exert an inde-
pendent effect on risk of readmission. Factors considered
potential confounders were FEV1,a g e ,s e x ,s m o k i n gs t a -
tus, comorbidity, and previous COPD admission.
Data on diagnosis, comorbidities, lung function, and
arterial blood gases were extracted at baseline from EDS
electronic case records. Comorbidities were extracted
from the case notes and measured using the Charlson
Comorbidity Index (CCI) [25], which is an extensively
used comorbidity index with predictive validity for a
range of outcomes, including readmission and death
[26]. The CCI comprises 19 medical conditions
weighted 1-6 on the basis of their association with mor-
tality, with total scores ranging from 0-37. We used the
age-adjusted CCI [27], and calculated the score using a
Microsoft Excel Macro [28]. Information on readmis-
sions for acute exacerbation was collected by the EDS
specialist respiratory nurses from records and updated
monthly. Hospital admissions for non-COPD related
events were excluded from the analysis but all patients
continued to be followed-up for 12 months unless cen-
sored at time of death.
Sociodemographic and socio-economic data were col-
lected using a self-report questionnaire given to partici-
pants at baseline. This included items for date of birth,
sex, ethnicity, education, living arrangements (owner-
occupier, tenant, sheltered accommodation, other), and
access to transport. Socio-economic deprivation was
measured using Carstairs scores (derived from post
codes) based on published 2001 UK Census data. The
Carstairs index is scored using unweighted combinations
of four census variables (unemployment, overcrowding,
car ownership, and low social class) [29]. Each census
variable is standardised (z-scored) to avoid the score
being unduly influenced by a high or low value for any
one variable and to put each variable on the same scale,
centred around zero. This is done for each variable by
subtracting the mean of the observations of each vari-
able (taken from all wards in England and Wales) from
the value of that variable for a specific ward and divid-
ing by the standard deviation for that variable. Values
for each variable are then summed to give an overall
score. Higher scores indicate worse deprivation [30].
HRQOL was measured at baseline and follow-up
using the St. George’s Respiratory Questionnaire
(SGRQ), a disease-specific self-report instrument [31].
Along with domain scores a total score can be calcu-
lated from 0-100; higher scores are indicative of poorer
HRQOL. The threshold for clinical significance or mini-
mal clinically significant difference (MCSD) on the
SGRQ total score is a change in 4 units [32].
Symptoms of anxiety and depression were measured
at baseline and follow-up using the Hospital Anxiety
and Depression Scale (HADS) [33]. The HADS is a 14-
item self-reported questionnaire comprising two scales
scored 0-21 to detect the presence and severity of anxi-
ety and depression. Severity scores for both sub-scales
are interpreted as: non-cases (0-7); mild cases (8-10);
moderate cases (11-14), or severe cases (15-21). A cut-
off of ≥15 on the total HADS score is regarded as indi-
cative of clinically significant emotional distress [34].
HADS can be used as both a screening tool and to
monitor changes over time. Thresholds for the MCSD
on the HADS in COPD patients have recently been
established, amounting to 1.5 or a change of about 20%
on either sub-scale and the total score [35].
Social support was measured at baseline and follow-up
with a self-report instrument originally developed for
the Enhancing Recovery in Coronary Heart Disease
( E N R I C H D )t r i a l[ 3 6 ] .T h eE N R I C H DS o c i a lS u p p o r t
Inventory (ESSI) includes 7 items that measure levels of
perceived emotional support (presence/absence and fre-
quency of a close confidant), instrumental support (tan-
gible or practical support), and informational support
(advice and problem solving). The ESSI therefore cap-
tures important data associated with perceived emo-
tional support which is regarded as the most sensitive
measure of individuals’ ability to cope with mental and
a broad range of physical health problems [37]. Low
perceived social support is defined by a score of less
than 3 on two or more items and a total score of less
than 18, or a score of 2 on 2 items irrespective of the
total score [38]. This is the first time the ESSI has been
used in a COPD population.
Statistical analysis
Logistic and survival models produce stable estimates if
t h el i m i t i n gs a m p l es i z ea l l o w sf o rar a t i oo f1 0 - 1 5
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vious data on readmission rates for AECOPD and attri-
tion rates dues to death [40] it was estimated that a
sample of 150 would yield 100 events for a regression
model.
In the statistical analysis readmission status, sex,
home ownership, and previous hospital admission were
dichotomised. Predictor variables (SGRQ, HADS, ESSI,
Carstairs) were used as continuous scores; other covari-
ates (age, age-adjusted CCI, FEV1) were treated as con-
tinuous. T-tests were used to compare group means for
normally distributed variables and the Mann-Whitney U
test was used for those variables not normally distribu-
ted. Univariate logistic regression models were fitted to
estimate whether baseline psychosocial factors (SGRQ,
HADS anxiety, HADS depression, ESSI, Carstairs) were
associated with readmission within 365 days with signif-
icance at p < 0.10. Variables that were significant at p <
0.10 were entered into the multivariable regression
models but were only included in the final parsimo-
nious models if p < 0.05. Multiple logistic regression
w a su s e dt oe s t a b l i s ha d j u s t e do d d sr a t i o s( O R s )a n d
95% confidence intervals (CIs) for readmission at p <
0.05. Cox regression was used to estimate hazard ratios
(HRs) and 95% CIs for time-to-first event following
index admission with significance at p < 0.05. A gener-
alised linear model with a Poisson link function was
used to model the number of admissions in 365 days.
All analysis was conducted using SPSS version v15.0
(SPSS Inc, Chicago, Ill).
This study (reference: 07/Q1402/19) was approved by
Tameside and Glossop Local Research Ethics Commit-
tee, UK.
Results
During the recruitment period 1153 patients were
admitted for AECOPD across north, south and central
Manchester and approximately 29% of these patients
were accepted onto EDS delivered across the study 3
sites. Of these, 123 patients were then invited by specia-
list respiratory nurses to enter the cohort study. Of
these 43 refused to participate. A total of 80 (65%)
patients entered the study. One patient was subse-
quently excluded by the cohort study team after being
diagnosed with lung cancer; no other patients referred
to EDS and invited to take part in the cohort study
were excluded.
Of these 79 patients, 17 (21%) patients died during
follow-up, 67 (85%) patients completed follow-up at 90
days, and 62 (78%) patients completed follow-up at 365
days. A total of 107 hospital admissions were recorded.
Twenty six (33%) patients were readmitted within 90
days, and 60 (76%) patients were readmitted at least
once after the index admission.
Compared with those not readmitted, patients read-
mitted were older, had poorer lung function and a
greater proportion had had a previous hospital admis-
sion for COPD (p < 0.05) (Table 1). The proportion of
patients with anxiety (58%) and depressive (43%) symp-
toms was high. Depression was more severe among
t h o s er e a d m i t t e db u tn o ts i g nificantly so. Similarly,
HRQOL was poorer among those readmitted but not to
a statistically significant degree. The majority of patients
had high levels of perceived social support; 25% had low
social support on the ESSI.
Adjusted for covariates selected from the univariate
analysis the most parsimonious model in the multivari-
ate analysis showed that baseline depression was signifi-
cantly associated with readmission within 365 days
(Table 2).
In Cox regression analysis only FEV1%a d j u s t e df o r
sex and age was a significant predictor of time to read-
mission or death (HR 0.97, 95% CI 0.95 to 0.99, p =
0.003). Adjusted for covariates selected from the uni-
variate analysis, the multivariate Poisson regression
(generalised linear model) analysis reveals that home
ownership is associated with the total number of read-
missions over 365 days: patients owning and occupying
their homes had fewer readmissions (B -0.46, 95% CI
-0.86 to -0.06, p = 0.024). Worse lung function (FEV1)
is also associated with the total number of readmis-
sions over 365 days (B -0.01, 95% CI -0.03 to 0.00, p =
0.009).
There are no significant differences in changes in
HRQOL, anxiety, depressive symptoms, and social sup-
port from baseline to 90 days for each group. However,
mean changes in anxiety and depressive symptoms from
baseline to 90 days exceeds the 20% MCSD on the
HADS total for the group not readmitted (mean change
-2.6, 95% CI -5.0 to -0.2) but not for the readmitted
group (mean change -0.6, 95% CI -2.7 to 1.5). Similarly,
decrements in HRQOL on the total SGRQ at 90 days
approach clinical significance among the readmitted
group (mean change 3.8, 95% CI 0.7 to 8.3). Changes on
the ESSI are negligible, and not significant.
We also analysed changes in HRQOL, anxiety and
depression, and social support from 90 days to 365 days
for each group. The change in SGRQ score is signifi-
cantly different (t = 2.163, df = 59, p = 0.035) for the
readmitted group (mean change 6.8, 95% CI 3.0 to
10.6). Decrements exceeded the MCSD difference on
the HADS total (mean difference 3.4, 95% CI 1.9 to 4.8)
for the readmitted group. These longitudinal trends are
illustrated in Figures 1, 2 and 3 which show that
HRQOL and psychological morbidity consistently dete-
riorated over 365 days among readmitted patients. By
contrast, for patients not readmitted, estimates for
SGRQ, HADS total, and HADS depression at each time
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remained stable over 365 days.
Discussion
In keeping with previous work on risk factors for read-
mission this study shows that age, lung function, and
previous hospital admission are the most powerful pre-
dictors of readmission for AECOPD. However, this is
the first prospective study to report that depressive
symptoms recorded after discharge are associated with
increased risk of readmission over 365 days and that an
individual marker of socio-economic deprivation
(owner-occupiers) are associated with the frequency of
hospital readmission for AECOPD in patients cared for
by nurse led EDS. Additionally, we found that compared
with those not readmitted, readmitted patients had
poorer HRQOL and worse depression and anxiety at 12
months follow-up.
Whilst hospital readmission might be unavoidable and
necessary for some patients with AECOPD, psychosocial
factors might account for a significant proportion of
potentially unnecessary readmissions among the most
vulnerable patients managed by EDS. Unlike Ng et al
[20] we did not find an association between mortality
and depression, mainly because our study was not ade-
quately powered to examine this endpoint. However, in
accounting for our findings about readmission possible
mechanisms might relate to the finding that frequent
exacerbators are more depressed than infrequent exacer-
bators [41], and depressed patients have a higher risk of
Table 1 Baseline characteristics of patients included in the study by readmission status over 365 days.
All Not readmitted Readmitted p-value
Subjects n 79 19 60
Age yrs 65.3 ± 9.9 61.2 ± 8.7 66.6 ± 10.0 0.036
Sex
male n (%) 44 (56) 10 (23) 34 (77) 0.965
female n (%) 35 (44) 9 (26) 26 (74)
Carstairs score 5.48 ± 3.14 5.52 ± 3.5 5.47 ± 3.0 0.952
Smoking status
Current n (%) 37 (47) 12 (32) 25 (68) 0.170
Ex/Never n (%) 42 (53) 7 (17) 35 (83)
Home ownership
yes (%) 48 (61) 7 (23) 24 (77)
no (%) 31 (39) 12 (25) 36 (75) 0.806
FEV1% predicted 42.2 ± 18.4 54.0 ± 19.8 38.4 ± 16.4 0.001
Previous COPD admission
yes (%) 66 (83) 12 (18) 54 (82)
no (%) 13 (17) 7 (54) 6 (46) 0.017
Age adjusted CCI 3.0 (3-4) 3.0 (2-4) 3.0 (3-4.75) 0.058
SGRQ total 58.8 ± 14.6 56.77 ± 13.7 59.51 ± 14.9 0.480
HADS-Anxiety 8.8 ± 4.3 9.47 ± 4.6 8.53 ± 4.2 0.407
HADS-Depression 7.0 ± 3.8 5.58 ± 3.5 7.45 ± 3.8 0.060
HADS-Total 15.8 ± 7.0 15.05 ± 7.2 15.98 ± 6.9 0.615
ESSI total 29 (22-32) 30 (25-32) 27 (21-32) 0.372
All data are presented as mean ± SD, median (interquartile range) or number and %. The p-value corresponds to the results from the t-test (mean ± SD) or
Mann-Whitney test (median, interquartile range) for continuous variables and the chi-square test for categorical variables.
CCI: Charlson Comorbidity Index; ESSI: Enhancing Recovery in Coronary Heart Disease Social Support Inventory; FEV1: forced expiratory volume in 1 second;
HADS: Hospital Anxiety and Depression Scale; IQR: Interquartile range; SGRQ: St George’s Respiratory Questionnaire.
Table 2 Risk factors for readmission in 365 days by multiple logistic regression
Baseline variable b coefficient SE Odds Ratio 95% CI p-value
Sex (female) 0.511 0.659 1.666 0.46-6.06 0.438
Age 0.088 0.039 1.092 1.01-1.18 0.026
FEV1% -0.039 0.017 0.962 0.93-0.99 0.021
HADS - depression 0.262 0.106 1.300 1.06-1.60 0.013
Smoker (yes) -1.264 0.677 0.282 0.75-1.07 0.062
Data presented as odds ratios (95% confidence intervals). FEV1: forced expiratory volume in 1 second; HADS: Hospital Anxiety and Depression Scale; SE: Standard
error
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precise relationship between psychological distress and
exacerbation risk has yet to be adequately addressed
however. The majority of studies that have tested asso-
ciations between psychological distress and exacerbation
risk are methodologically weak, leading to inconsistent
and heterogeneous results. The best available evidence
suggests that psychological distress might confer greater
risk for symptom based as opposed to event-based
exacerbations that demand therapeutic interventions
and/or possibly hospital admission, but this conclusion
warrants further scrutiny from well designed prospective
studies [42]. Furthermore, risk factors for relapse asso-
ciated with treatment failure of a first exacerbation may
well be different to risk factors associated with readmis-
sions following successful treatment of exacerbations
that are discrete events.
It is surprising that we did not find a similar associa-
tion between anxiety and readmission. Panic attacks and
panic disorder are the most common anxiety disorders
among COPD patients owing to heightened physical
arousal following catastrophic negative cognitions of
ambiguous physical sensations such as shortness of
breath [43]. However the HADS does not specifically
measure panic disorder and item 7 related to panic
demonstrates item bias for severity of illness among
COPD patients [44]. Because we used the HADS we
therefore might have been unable to detect whether
panic attacks were associated with risk of readmission.
Social factors are also important determinants of
healthcare utilisation. There is growing evidence from
ecological studies that socio-economic status is a key
driver of respiratory hospital admissions, but evidence
from individual level measures of socio-economic depri-
vation is more equivocal [45]. Contrary to expectation
we did not find an association between the Carstairs
deprivation index and risk of readmission, despite the
fact that the Carstairs index is known to outperform
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This may have been due to the absence of variation
among Carstairs scores among this study population,
suggesting that this measure is prone to the ecological
fallacy.
We did however show that patients who owned and
occupied their homes had significantly fewer readmis-
sions. Home ownership, especially in the UK, is a well
established indicator of material living standards and
long-term cumulative wealth [46]. Our findings are in-
keeping with other studies that have shown that home
ownership exhibits stronger associations with health
than conventional markers of socio-economic status
such as income, education, and occupational and social
class [47]. Further, housing-related health hazards (e.g.
damp, cold) typically associated with poorer quality of
housing among renters is associated with poorer health
[48], and housing conditions have been implicated with
respiratory health status and hospital admission [24].
Unlike socio-economic status, low perceived social
support was not associated with risk of readmission.
This sample reported high levels of social support at
baseline and ESSI scores remained stable throughout
f o l l o w - u p .O v e rt h el i f ec o u r s eo fac h r o n i ci l l n e s ss u c h
as COPD, perceived social support fluctuates - it grows
or decays in the presence or absence of acute stressors
[49]. This sample was regularly exposed to stressful
events i.e. exacerbations and admissions, and these
events may have contributed to the maintenance of high
levels of social support at 3 and 12 months. In addition,
the relatively high scores on the ESSI may have reflected
the fact that only patients with adequate social support
or were self-caring were eligible for referral to EDS at
the study sites. An alternative methodological explana-
tion points to the fact that whilst the ESSI only contains
generic questions related to perceived social support,
this instrument might have a different factorial structure
when used with COPD patients. The ESSI might there-
fore measure either different constructs or measure per-
ceived social support differently in COPD patients.
By contrast, psychological health and HRQOL deterio-
rated at 12 months for patients who were readmitted,
but remained stable among patients not readmitted. The
reasons for this trend are not clear because we were
unable to assess whether changes in psychological dis-
tress (anxiety and depressive symptoms) and HRQOL
led to increased risk of readmissions, or whether
increased readmissions led to a change in psychological
distress and HRQOL. Among COPD patients, psycholo-
gical health is known to deteriorate over time and these
changes are only weakly correlated with changes in phy-
siological parameters, highlighting the fact that COPD
exerts its effects in body systems other than the lungs
and requires multi-dimensional assessment [50].
This study included a self-selected sample drawn from
UK EDS and patients who declined to participate may
well have had more elevated symptoms of anxiety and
depression than those who did enrol in the study. This
group may also have represented an atypical group of
patients who were willing to take part in a research
study and their responses may have been affected by
social desirability bias. Additionally, we did not have
ethical approval to collect data from non-participants,
limiting opportunities to compare characteristics such as
age, sex and smoking status between refusals and parti-
cipants. For these reasons the results may not be gener-
alisable to wider COPD populations and settings where
EDS is not available. However, whilst patients on EDS
represent only a well supported sub-set of the total
COPD patient population, they are among the most vul-
nerable and use a disproportionate amount of healthcare
resources [51]. We therefore specifically recruited
patients on EDS to identify psychosocial characteristics
that might be associated with risk of readmission among
a group of vulnerable patients that are high intensity
users of healthcare.
Despite targeting patients on EDS in three hospitals
this study had low uptake and the results should there-
fore be deemed exploratory and interpreted cautiously.
The reasons for under recruiting are uncertain. Patients
who receive home based interventions such as EDS
might perceive the prospect of additional home visits
from researchers as too intrusive and burdensome, but
there is little evidence for this. Indeed, on the contrary,
patients with chronic illness, especially those with severe
or end stage illness, may well welcome opportunities to
engage in research as it might confer therapeutic bene-
fits [52] and appeal to a sense of altruism [53]. These
perceived benefits may well have motivated patients to
participate in this study. The more plausible reason for
under recruitment stems from the fact that the research
team were not sufficiently embedded within the clinical
teams, leading to over reliance on specialist nurses, who
were not ordinarily research active or afforded research
time to identify and recruit eligible patients. When
working with non-research active clinicians, recruitment
needs to be incentivised, either financially, or by secur-
ing continuing professional development credits for time
spent on research activities.
The principal investigator collected data at all time
points during this study and was not blind to patients’
baseline psychological status, potentially leading to mea-
surement bias. However, patients’ psychological health
status was measured using self-report rather than inves-
tigator led questionnaires limiting opportunities for the
principal investigator to introduce measurement bias.
Additionally, all follow-up questionnaires were scored
by an independent research administrator at the end of
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investigator was not exposed to patients’ follow-up
scores on the HADS, SGRQ or ESSI, potentially mini-
mising measurement bias during the study follow-up.
We conducted three different separate regression ana-
lyses: logistic regression to assess which predictors were
associated with readmission within 365 days, Cox
regression to assess which predictors were associated
with time to first event (readmission or death), and
Poisson regression to assess which predictors were asso-
ciated with the number of readmissions. The final
regression models included a set of a priori predictors
(age and sex) and measured the effects of as many
known confounders within sample size limits. We
avoided overfitting the models and preserved degrees of
freedom, an approach which is transparent and poten-
tially replicable in other samples [54]. The models
demonstrated that worse lung function (FEV1) was asso-
ciated with all three outcomes, depression score was
associated with readmission within 365 days, and home
ownership was associated with fewer admissions. A lar-
ger sample size may have allowed us to explore these
apparent relationships further, and perhaps with more
power, we would have arrived at more consistent results
over the three regression models.
We did not enter into the models data on treatments,
including medications for psychological distress which
would have allowed us to examine whether treatment
for anxiety and/or depression reduced the risk of read-
mission. Further, we did not collect data on whether
patients had received pulmonary rehabilitation which is
known to improve anxiety and depressive symptoms in
some COPD patients [55]. Resource constraints did not
allow for longitudinal assessment of lung function
(FEV1), thus limiting opportunities to examine whether
changes in disease severity were associated with dete-
riorations in patient reported outcomes. However, in
recognition that COPD is a multi-component disease
with systematic manifestations, we prospectively mea-
sured patient reported outcomes such as HRQOL which
are possibly more important markers of disease progres-
sion and severity than lung function alone [56]. In addi-
tion we also collected both individual and area-based
measures of socio-economic status which is a methodo-
logical strategy known to capture important differences
in social and economic status [57]. Collecting individual
level data on home ownership is particularly relevant to
research involving patients who are typically older and/
or retired adults for whom the importance of other indi-
cators of socio-economic status is much reduced [47].
Identifying and improving the health of patients with
complex long term conditions at most risk of unplanned
and unnecessary secondary care has become a key
objective of advanced healthcare systems such as the
NHS [51]. Case finding tools now exist to identify
patients at high risk of hospital readmission within 12
months [58], but isolating specific characteristics asso-
ciated with unnecessary or preventable readmissions has
proven difficult. Identifying deteriorations in psychologi-
cal distress may improve current case finding models
for patients at risk of hospital readmission.
Designing interventions to reduce the risk of hospital
readmission for AECOPD remains a challenge however.
As with EDS, there is little evidence that nurse-led
chronic disease management programmes that offer var-
iations of case-management reduce readmissions [59].
Nor do written action plans with minimal or no self-
management education [60]. In designing interventions
that enhance the management of AECOPD patients out
of hospital there is scope for evaluating interventions
that target identifiable and modifiable risk factors [14].
Psychosocial factors such as depression are potential
therapeutic targets and nurse-led minimal psychological
interventions have proven effective in managing depres-
sion in chronically ill elderly patients [61]. In the UK,
the National Institute for Health and Clinical Excellence
have published guidelines that incorporate stepped care
models to facilitate the delivery of accessible and effec-
tive treatments for treating depression in people with
chronic physical illness [62]. However, despite evidence
that supports the efficacy of antidepressants and struc-
tured forms of psychotherapy, depression remains
under-detected and under treated, especially among
older adults and in patients with medical comorbidity
[63]. There is thus scope to design and evaluate models
of care that might improve the detection and manage-
ment of psychological distress among vulnerable COPD
patients discharged home and reduce demand for unne-
cessary and unscheduled hospital admissions.
Conclusion
Depression in patients discharged to EDS following
AECOPD is an independent risk factor for hospital
readmission. Home ownership is also implicated in the
frequency of readmissions for AECOPD. However, per-
ceived levels of social support were not significantly
associated with risk of readmission in this group of
patients referred to EDS. Future work could focus on
ways to support the psychosocial care of patients dis-
charged home early after AECOPD, especially those
with depressive symptoms.
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